Saturday, July 11, 2026

Drug profile · INN

fluorodopa f-18

fluorodopa f-18 (FLUORODOPA F18) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — fluorodopa f-18
US status
approved
Class
Route
INTRAVENOUS
Patents
0
Programs
1
Data quality
0.84

Quick answer

fluorodopa f-18 (FLUORODOPA F18) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN fluorodopa f-18
Brand FLUORODOPA F18
Mechanism Diagnostic agent
Route INTRAVENOUS
Formulation SOLUTION

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Fluorodopa F 18 Phase 2 · BRIGHT MINDS BIOSCIENCES · Malignant Brain Neoplasm

Frequently asked questions

What is fluorodopa f-18?

fluorodopa f-18 (FLUORODOPA F18) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for fluorodopa f-18?

FLUORODOPA F18 is a marketed brand name for fluorodopa f-18. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fluorodopa f-18?

fluorodopa f-18 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.